Skip to main content

BlueCross BlueShield Extends Coverage of Coronavirus Treatment

May 30, 2020

To ensure members continue to have access to the care they need during the COVID-19 pandemic, BlueCross BlueShield of Western New York will continue to waive all copays, coinsurance and deductibles for COVID-19 treatment received by fully insured Commercial and Medicare Advantage members through June 30, an extension from the original announcement that was set to end May 31, 2020.

“The health and well-being of our members is what is most important to us. We’ve been here for our members through the pandemic, and we want them to know that we will continue to be here for them,” said David W. Anderson, President and CEO, BlueCross BlueShield of Western New York. “Even as the number of COVID-19 confirmed cases, hospitalizations and deaths have decreased in our region, we still believe that by eliminating member cost-share for these treatments, we’re ensuring that our members have full access to the treatment and medical attention they need to get and stay healthy.”

The company’s announcement today builds on its overall efforts to connect members to care during this time. In addition to covering the full cost of COVID-19 testing and treatment and telehealth services since the beginning of April, BlueCross BlueShield has also eliminated prior authorization requirements for COVID-19 testing and treatment through June 18; authorized 90-day mail order benefit for refills of all applicable prescriptions; donated funds to the WNY COVID-19 Response Fund to address the most critical and immediate community needs as well as other efforts; and dedicated a team to provide personal outreach and support to members during this time of uncertainty.

The health plan will continue to monitor regional health and claims data with the intent to resume normal claims processing procedures aligned with specific member’s health plans regarding deductibles, co-pays, and co-insurance on July 1, 2020.

In some instances, BlueCross BlueShield members are covered under a health plan that is self-insured by their employer. Self-insured employers will have the flexibility to apply the same no-cost structure but may opt-out of this treatment waiver. To ensure out-of-pocket costs are not a barrier to people seeking treatment of COVID-19, the local health plan is helping local employers in making decisions about their health plans.